治疗遗传性视网膜疾病所致黄斑新生血管的临床结局：文献综述。

Clinical outcomes of treated macular neovascularisation secondary to inherited retinal diseases: a literature review.

机构信息

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

出版信息

BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001309.

DOI:10.1136/bmjophth-2023-001309

PMID:37493670

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10364169/

Abstract

Many inherited retinal diseases (IRD) can be associated with, or be secondarily complicated by, macular neovascularisation (MNV), which has been variably treated with intravitreal antivascular endothelial growth factor, steroids, laser and surgery. In this article, we aim to present a consolidated literature review of management of IRD-related MNV.

摘要

许多遗传性视网膜疾病（IRD）可伴有或继发黄斑新生血管（MNV），其治疗方法因血管内皮生长因子抑制剂、皮质类固醇、激光和手术等而异。本文旨在对与 IRD 相关的 MNV 的治疗进行综合文献回顾。